Stay updated on Favipiravir Clinical Trial: Influenza Efficacy & Safety
Sign up to get notified when there's something new on the Favipiravir Clinical Trial: Influenza Efficacy & Safety page.

Latest updates to the Favipiravir Clinical Trial: Influenza Efficacy & Safety page
- Check2 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1.SummaryDifference0.0%

- Check9 days agoChange DetectedAdded a 'Show glossary' option and QC/versioning metadata (Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0). Removed the older labeled items with different capitalization and an older revision (Last Update Submitted that met QC Criteria, No FEAR Act data, Revision: v3.3.4).SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedPage revision updated from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check45 days agoChange DetectedAdded a Locations section detailing study sites across multiple states, countries, and cities, broadening enrollment sites.SummaryDifference3%

- Check73 days agoChange DetectedPublications section now states that PubMed-sourced publications are automatically populated and may not all relate to the study, and the revision version updated to v3.3.2 (replacing v3.2.0).SummaryDifference0.4%

- Check81 days agoChange DetectedDeleted the boilerplate government funding/operating status notice from the page. Core study details, eligibility criteria, and locations remain unchanged.SummaryDifference0.1%

Stay in the know with updates to Favipiravir Clinical Trial: Influenza Efficacy & Safety
Enter your email address, and we'll notify you when there's something new on the Favipiravir Clinical Trial: Influenza Efficacy & Safety page.